P. C. van de Meeberg

发表

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

E. Dekker, J. Kleibeuker, F. Nagengast, 2010, Gastroenterology.

No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.

M. Kloor, M. von Knebel Doeberitz, C. Strassburg, 2018, Gastroenterology.

Increasing fish consumption does not affect genotoxicity markers in the colon in an intervention study.

N. Habermann, A. Geelen, F. Nagengast, 2010, Carcinogenesis.

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

P. Siersema, D. D. de Jong, C. Ponsioen, 2016, PloS one.

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

M. V. van Oijen, P. Siersema, D. D. de Jong, 2012, Gut.

The Polyp Manager: a new tool for optimal polyp documentation during colonoscopy. A pilot study.

P. C. T. ter Borg, R. Ouwendijk, S. J. van den Hazel, 2016, Endoscopy International Open.

Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy.

P. Siersema, D. D. de Jong, C. Ponsioen, 2015, Journal of Crohn's & colitis.

Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.

M. V. van Oijen, P. Siersema, D. D. de Jong, 2014, Journal of Crohn's & colitis.

Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.

M. Kloor, M. von Knebel Doeberitz, A. Stenzinger, 2020, Gastroenterology.

Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

P. Siersema, D. D. de Jong, C. Ponsioen, 2016, Journal of Crohn's & colitis.

Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock‐wave lithotripsy

P. Portincasa, T. D. de Bruin, K. V. van Erpecum, 1996, Hepatology.

Risk of primary sclerosing cholangitis is associated with nonsmoking behavior.

A. Algra, K. V. van Erpecum, F. Linn, 1996, Gastroenterology.

Effects of Ursodeoxycholic Acid Therapy on In Vitro Gallbladder Contractility in Patients with Cholesterol Gallstones

F. Hoebers, H. Doornewaard, P. Portincasa, 2004, Digestive Diseases and Sciences.

Increased Belching After Sleeve Gastrectomy

P. Siersema, E. Schoon, A. Smout, 2015, Obesity Surgery.

Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease

P. Siersema, D. D. de Jong, C. Ponsioen, 2016, Journal of Crohn's & colitis.

Increased gall bladder volume in primary sclerosing cholangitis.

P. Portincasa, K. V. van Erpecum, G. P. vanBerge-Henegouwen, 1996, Gut.

Systematic review: the effects of conservative and surgical treatment for obesity on gastro‐oesophageal reflux disease

P. Siersema, A. Smout, N. L. Groot, 2009, Alimentary pharmacology & therapeutics.

Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.

K. V. van Erpecum, G. P. van Berge‐Henegouwen, J. van Hattum, 1996, Journal of hepatology.

Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.

Jingyuan Fu, A. Zhernakova, C. Wijmenga, 2021, Gastroenterology.

An update on the pathogenesis and treatment of cholesterol gallstones.

P. Portincasa, K. V. van Erpecum, G. Palasciano, 1997, Scandinavian journal of gastroenterology. Supplement.

Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome: Partial Versus Subtotal Colectomy

E. Dekker, J. Kleibeuker, F. Nagengast, 2012, Diseases of the colon and rectum.

R. Weersma, C. Ponsioen, Eleonora A. M. Festen, 2018, Inflammatory bowel diseases.

Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up.

C. Bijleveld, H. Heijerman, M. Sinaasappel, 1997, Scandinavian journal of gastroenterology.

Nocturnal and daytime esophageal acid exposure in normal-weight, overweight, and obese patients with reflux symptoms

P. Siersema, A. Smout, J. Burgerhart, 2014, European journal of gastroenterology & hepatology.

Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease: A Glimpse into the Future

P. Siersema, D. D. de Jong, C. Ponsioen, 2014, Inflammatory bowel diseases.

Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease

P. Siersema, D. D. de Jong, C. Ponsioen, 2017, Inflammatory bowel diseases.

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.

W. Hop, F. T. ten Kate, H. V. van Buuren, 1998, Journal of hepatology.

Self-reported Disability in Patients with Inflammatory Bowel Disease Largely Determined by Disease Activity and Illness Perceptions

P. Siersema, D. D. de Jong, C. Ponsioen, 2015, Inflammatory bowel diseases.

Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies.

A. Geelen, F. Nagengast, G. Schaafsma, 2010, The Journal of nutrition.

Cholestatic liver diseases: new strategies for prevention and treatment of hepatobiliary and cholestatic diseases.

K. V. van Erpecum, G. P. van Berge Henegouwen, P. C. van de Meeberg, 1995, The Netherlands journal of medicine.

Fish consumption and markers of colorectal cancer risk: a multicenter randomized controlled trial.

A. Geelen, Matthew P. Williams, F. Nagengast, 2009, The American journal of clinical nutrition.

Prospective Risk Assessment of Endoscopic Retrograde Cholangiography in Patients with Primary Sclerosing Cholangitis

H. V. van Buuren, D. V. van Leeuwen, D. J. Leeuwen, 2000, Endoscopy.

Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease

A. Geelen, H. Boshuizen, E. Kampman, 2018, Supportive Care in Cancer.

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

E. Dekker, J. Kleibeuker, F. Nagengast, 2010, Gastroenterology.

Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome: Partial Versus Subtotal Colectomy

E. Dekker, J. Kleibeuker, F. Nagengast, 2011, Diseases of the colon and rectum.